Ryan Ho-Yan Wong

CIK: 0002079673

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)8 (80.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SRPT

Sarepta Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

SRPT
Sarepta Therapeutics, Inc.
Sep 4, 2026
Tax Payment(F)
Direct
13.3K shares at avg. $22.22$295K
SRPT
Sarepta Therapeutics, Inc.
Mar 11, 2026
Tax Payment(F)
Direct
256 shares at avg. $17.03$4K
SRPT
Sarepta Therapeutics, Inc.
Mar 9, 2026
Tax Payment(F)
Direct
162 shares at avg. $16.95$3K
SRPT
Sarepta Therapeutics, Inc.
Mar 9, 2026
Tax Payment(F)
Direct
113 shares at avg. $16.95$2K
SRPT
Sarepta Therapeutics, Inc.
Mar 2, 2026
Tax Payment(F)
Direct
450 shares at avg. $16.20$7K
SRPT
Sarepta Therapeutics, Inc.
Dec 1, 2025
Tax Payment(F)
Direct
80 shares at avg. $20.96$2K
SRPT
Sarepta Therapeutics, Inc.
Dec 1, 2025
Tax Payment(F)
Direct
78 shares at avg. $20.96$2K
SRPT
Sarepta Therapeutics, Inc.
Sep 3, 2025
Award(A)
Direct
25K shares-
SRPT
Sarepta Therapeutics, Inc.
Sep 3, 2025
Award(A)
Direct
93.9K shares-
SRPT
Sarepta Therapeutics, Inc.
Jul 31, 2025
Tax Payment(F)
Direct
327 shares at avg. $16.42$5K

		Type	Shares	Price		Ownership
Sep 4, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	13,272	$22.22	$294,904	Direct
Mar 11, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	256	$17.03	$4,360	Direct
Mar 9, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	162	$16.95	$2,746	Direct
Mar 9, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	113	$16.95	$1,915	Direct
Mar 2, 2026	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	450	$16.20	$7,290	Direct
Dec 1, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	80	$20.96	$1,677	Direct
Dec 1, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	78	$20.96	$1,635	Direct
Sep 3, 2025	SRPT Sarepta Therapeutics, Inc.	Award(A)	25,000	-	-	Direct
Sep 3, 2025	SRPT Sarepta Therapeutics, Inc.	Award(A)	93,875	-	-	Direct
Jul 31, 2025	SRPT Sarepta Therapeutics, Inc.	Tax Payment(F)	327	$16.42	$5,369	Direct

1-10 of 10 transactions

About Wong Ryan Ho-Yan

Wong Ryan Ho-Yan (SEC CIK 0002079673) files insider reports with the SEC as Chief Financial Officer of Sarepta Therapeutics, Inc. (SRPT).

Signal8 holds 8 ownership filings by Wong Ryan Ho-Yan (1 Form 3, 7 Form 4), filed between Aug 4, 2025 and Sep 8, 2026. Those filings report 10 transactions, from Jul 31, 2025 to Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Wong Ryan Ho-Yan's filings is in CAMBRIDGE, MA.

Recent filings by Wong Ryan Ho-Yan

Sep 4, 2026: Tax withholding of SRPT shares (Form 4, code F).
Mar 11, 2026: Tax withholding of SRPT shares (Form 4, code F).
Mar 9, 2026: Tax withholdings of SRPT shares (2 lines, Form 4, code F).
Mar 2, 2026: Tax withholding of SRPT shares (Form 4, code F).
Dec 1, 2025: Tax withholdings of SRPT shares (2 lines, Form 4, code F).

Other insiders filing for Sarepta Therapeutics, Inc. (SRPT)

Estepan Ian Michael, Chief Operating Officer
Rothfuss Cristin, EVP, General Counsel
Rodino-Klapac Louise, President, R&D and Tech Ops
SEVERINO MICHAEL, Chief Executive Officer
Boor Kathryn Jean, Director
Mayo Stephen, Director

How to read Form 4 transaction codes